Breaking News Instant updates and real-time market news.

NVS

Novartis

$88.00 /

+3.54 (+4.19%)

, BIIB

Biogen

$228.00 /

-1.05 (-0.46%)

13:30
05/24/19
05/24
13:30
05/24/19
13:30

ICER says Zolgensma price falls within upper bound of benchmark range

The Institute for Clinical and Economic Review said in a statement, "Zolgensma is dramatically transforming the lives of families affected by this devastating disease, and given the new efficacy data for the presymptomatic population, the price announced today falls within the upper bound of ICER's value-based price benchmark range. Insurers were going to cover Zolgensma no matter the price, and Novartis has spoken publicly about considering prices that approached $5 million. It is a positive outcome for patients and the entire health system that Novartis instead chose to price Zolgensma at a level that more fairly aligns with the benefits for these children and their families." Novartis (NVS) announced today that the FDA approved Zolgensma to treat pediatric patients less than two years of age with spinal muscular atrophy. Shares of Biogen (BIIB) and Ionis Pharmaceuticals (IONS) are trading lower following the approval of Zolgensma. Reference Link

NVS

Novartis

$88.00 /

+3.54 (+4.19%)

BIIB

Biogen

$228.00 /

-1.05 (-0.46%)

IONS

Ionis Pharmaceuticals

$65.44 /

-1.69 (-2.52%)

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

NVS Novartis
$88.00 /

+3.54 (+4.19%)

05/20/19 Credit Suisse
Regeneron initiated with a Neutral at Credit Suisse
05/20/19 RBC Capital
RBC says posting hints at Zolgensma label potentially positive for PTC, Biogen
05/17/19 Credit Suisse
Alcon off to 'solid start' post-Novartis spin, says Credit Suisse
05/13/19 Wells Fargo
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
BIIB Biogen
$228.00 /

-1.05 (-0.46%)

05/23/19
Biogen initiated with a Neutral at Wedbush
05/22/19
Citi assumes coverage of large-cap biotech, upgrades Amgen and Gilead
05/22/19 Wedbush
Biogen initiated with a Neutral at Wedbush
05/20/19 Credit Suisse
Biogen initiated with an Underperform at Credit Suisse
IONS Ionis Pharmaceuticals
$65.44 /

-1.69 (-2.52%)

05/24/19 Piper Sandler
Piper 'incrementally more positive' on Ionis after management meetings
05/09/19 Piper Sandler
Ionis Pharmaceuticals shares 'more interesting on pullback', says Piper Jaffray
05/07/19 Morgan Stanley
Biogen could rise, or fall, 5% based on Zolgensma label, says Morgan Stanley
05/07/19 Piper Sandler
Piper more confident in estimates for Alnylam's Onpattro after doctor survey

TODAY'S FREE FLY STORIES

Hot Stocks
Amdocs expands agreement with PLDT » 06:09
07/13/20
07/13
06:09
07/13/20
06:09
DOX

Amdocs

$59.01 /

+1.22 (+2.11%)

, PHI

PLDT

$27.67 /

-0.38 (-1.35%)

Amdocs (DOX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$59.01 /

+1.22 (+2.11%)

DOX Amdocs
$59.01 /

+1.22 (+2.11%)

02/05/20 Oppenheimer
Amdocs price target raised to $85 from $77 at Oppenheimer
11/15/19 Stifel
Amdocs price target raised to $75 from $70 at Stifel
08/08/19 JPMorgan
Amdocs price target raised to $75 from $67 at JPMorgan
PHI PLDT
$27.67 /

-0.38 (-1.35%)

03/25/20 JPMorgan
PLDT upgraded to Overweight from Neutral at JPMorgan (yesterday)
01/07/20 BofA
PLDT upgraded to Neutral from Underperform at BofA
01/06/20 Citi
PLDT upgraded to Neutral from Sell at Citi
DOX Amdocs
$59.01 /

+1.22 (+2.11%)

DOX Amdocs
$59.01 /

+1.22 (+2.11%)

Earnings
Axonics reports preliminary Q2 revenue $15.2M, consensus $5.19M » 06:07
07/13/20
07/13
06:07
07/13/20
06:07
AXNX

Axonics

$39.35 /

-1.88 (-4.56%)

Sales to customers in the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

AXNX Axonics
$39.35 /

-1.88 (-4.56%)

04/21/20 Piper Sandler
Axonics price target lowered to $44 from $48 at Piper Sandler
04/14/20 Piper Sandler
Axonics next-gen INS not compatible with InterStim II leads, says Piper Sandler
04/08/20 Wells Fargo
Axonics price target lowered to $35 from $47 at Wells Fargo
03/05/20 SunTrust
Axonics price target raised to $48 from $38 at SunTrust
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

  • 08
    May
  • 20
    Nov
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

Initiation
TAL Education resumed with a Buy at BofA » 06:07
07/13/20
07/13
06:07
07/13/20
06:07
TAL

TAL Education

$73.58 /

-2.88 (-3.77%)

BofA analyst Lucy Yu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

06/30/20 Goldman Sachs
TAL Education price target raised to $75 from $64 at Goldman Sachs
04/13/20 CLSA
TAL Education downgraded to Sell from Outperform at CLSA
04/08/20 GLJ Research
JinkoSolar price target lowered to $6.88 from $7.97 at GLJ Research
03/23/20 DBS Holding
TAL Education upgraded to Buy from Hold at DBS Holding
TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

Recommendations
Netflix price target raised to $625 from $500 at BMO Capital » 06:06
07/13/20
07/13
06:06
07/13/20
06:06
NFLX

Netflix

$548.56 /

+40.65 (+8.00%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

07/10/20 Goldman Sachs
Netflix price target raised to $670 from $540 at Goldman Sachs
07/10/20 Piper Sandler
Piper search index suggests inline Q2 sub results for Netflix
07/09/20 JPMorgan
JPMorgan raises Netflix sub addition estimate above Q2 guidance
07/08/20 Stifel
Netflix price target raised to $500 from $460 at Stifel
NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

Recommendations
U.S. Gold price target raised to $16.50 from $14.50 at H.C. Wainwright » 06:06
07/13/20
07/13
06:06
07/13/20
06:06
USAU

U.S. Gold

$7.40 /

+0.75 (+11.28%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAU U.S. Gold
$7.40 /

+0.75 (+11.28%)

Hot Stocks
Himax names Jessica Pan as CFO, Eric Li as Chief IR/PR Officer » 06:05
07/13/20
07/13
06:05
07/13/20
06:05
HIMX

Himax

$3.89 /

-0.055 (-1.40%)

Himax Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMX Himax
$3.89 /

-0.055 (-1.40%)

HIMX Himax
$3.89 /

-0.055 (-1.40%)

05/08/20 Lake Street
Himax challenges not due to change in competitive position, says Lake Street
04/01/20 Lake Street
Lake Street confident Himax positioned to see continued momentum
03/25/20 Baird
Himax emerging from transition, re- initiated with an Outperform at Baird
03/25/20 Baird
Himax reinstated with an Outperform at Baird
HIMX Himax
$3.89 /

-0.055 (-1.40%)

HIMX Himax
$3.89 /

-0.055 (-1.40%)

Hot Stocks
PepsiCo continues to see FY20 core effective tax rate of approx. 21% » 06:05
07/13/20
07/13
06:05
07/13/20
06:05
PEP

PepsiCo

$134.48 /

+1.82 (+1.37%)

The company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

Upgrade
Cognizant upgraded to Buy from Hold at HSBC » 06:05
07/13/20
07/13
06:05
07/13/20
06:05
CTSH

Cognizant

$55.78 /

+0.5 (+0.90%)

HSBC analyst Yogesh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

06/10/20 BofA
Cognizant upgraded to Neutral from Sell at BofA
06/10/20 BofA
Cognizant upgraded to Neutral from Underperform at BofA
05/08/20 Bernstein
Cognizant downgraded to Market Perform from Outperform at Bernstein
05/04/20
Fly Intel: Top five analyst downgrades
CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

CTSH Cognizant
$55.78 /

+0.5 (+0.90%)

Earnings
Maxim Integrated raises Q4 revenue view to ~$545M from $480M-$540M » 06:04
07/13/20
07/13
06:04
07/13/20
06:04
MXIM

Maxim Integrated

$64.10 /

-0.33 (-0.51%)

Consensus $511.23M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

04/29/20 Credit Suisse
Maxim Integrated price target lowered to $60 from $68 at Credit Suisse
03/30/20 Citi
Maxim Integrated price target lowered to $52 from $65 at Citi
03/20/20
Fly Intel: Top five analyst initiations
03/20/20 Nomura Instinet
Maxim Integrated initiated with a Neutral at Nomura Instinet
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

Hot Stocks
PepsiCo CEO: Business performed 'relatively well' during Q2 » 06:04
07/13/20
07/13
06:04
07/13/20
06:04
PEP

PepsiCo

$134.48 /

+1.82 (+1.37%)

"I'm very…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

Initiation
Royalty Pharma initiated with a Buy at BofA » 06:04
07/13/20
07/13
06:04
07/13/20
06:04
RPRX

Royalty Pharma

$47.55 /

-0.8 (-1.65%)

BofA initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

07/12/20 Goldman Sachs
Royalty Pharma initiated with a Neutral at Goldman Sachs
  • 16
    Jun
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

Hot Stocks
PepsiCo not proividing financial outlook for FY20 at this time » 06:03
07/13/20
07/13
06:03
07/13/20
06:03
PEP

PepsiCo

$134.48 /

+1.82 (+1.37%)

The company said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

Hot Stocks
Analog Devices to acquire Maxim Integrated in all stock transaction » 06:03
07/13/20
07/13
06:03
07/13/20
06:03
ADI

Analog Devices

$124.42 /

+0.14 (+0.11%)

, MXIM

Maxim Integrated

$64.10 /

-0.33 (-0.51%)

Analog Devices (ADI) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
05/21/20 Raymond James
Analog Devices price target raised to $125 from $100 at Raymond James
05/21/20 SunTrust
Analog Devices price target raised to $133 from $124 at SunTrust
05/21/20 RBC Capital
Analog Devices price target raised to $130 from $122 at RBC Capital
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

04/29/20 Credit Suisse
Maxim Integrated price target lowered to $60 from $68 at Credit Suisse
03/30/20 Citi
Maxim Integrated price target lowered to $52 from $65 at Citi
03/20/20
Fly Intel: Top five analyst initiations
03/20/20 Nomura Instinet
Maxim Integrated initiated with a Neutral at Nomura Instinet
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

Downgrade
Midland States downgraded to Neutral from Overweight at Piper Sandler » 06:03
07/13/20
07/13
06:03
07/13/20
06:03
MSBI

Midland States

$13.69 /

+0.61 (+4.66%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSBI Midland States
$13.69 /

+0.61 (+4.66%)

MSBI Midland States
$13.69 /

+0.61 (+4.66%)

04/09/20 Stephens
Stephens cuts Midland States to Equal Weight, prefers 'wait-and-see approach'
04/09/20 Stephens
Midland States downgraded to Equal Weight from Overweight at Stephens
04/01/20 Keefe Bruyette
Midland States downgraded to Market Perform from Outperform at Keefe Bruyette
MSBI Midland States
$13.69 /

+0.61 (+4.66%)

Earnings
PepsiCo reports Q2 core EPS $1.32, consensus $1.25 » 06:02
07/13/20
07/13
06:02
07/13/20
06:02
PEP

PepsiCo

$134.48 /

+1.82 (+1.37%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

Initiation
Ellington Financial initiated with a Neutral at BofA » 06:02
07/13/20
07/13
06:02
07/13/20
06:02
EFC

Ellington Financial

$11.23 /

+0.205 (+1.86%)

BofA initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFC Ellington Financial
$11.23 /

+0.205 (+1.86%)

EFC Ellington Financial
$11.23 /

+0.205 (+1.86%)

04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
09/27/19 Nomura Instinet
Ellington Financial initiated with a Buy at Nomura Instinet
EFC Ellington Financial
$11.23 /

+0.205 (+1.86%)

  • 22
    Jan
  • 19
    Nov
  • 18
    Jul
Earnings
Analog Devices raises Q3 adj. EPS view to $1.33 +/- 5c from $1.08 +/- 11c » 06:01
07/13/20
07/13
06:01
07/13/20
06:01
ADI

Analog Devices

$124.42 /

+0.14 (+0.11%)

Consensus $1.08. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
05/21/20 Raymond James
Analog Devices price target raised to $125 from $100 at Raymond James
05/21/20 SunTrust
Analog Devices price target raised to $133 from $124 at SunTrust
05/21/20 RBC Capital
Analog Devices price target raised to $130 from $122 at RBC Capital
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

Initiation
Roche initiated with an Outperform at Bernstein » 06:01
07/13/20
07/13
06:01
07/13/20
06:01
RHHBY

Roche

$0.00 /

+ (+0.00%)

Bernstein analyst Wimal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Analog Devices to acquire Maxim Integrated in all stock deal  06:00
07/13/20
07/13
06:00
07/13/20
06:00
ADI

Analog Devices

$124.42 /

+0.14 (+0.11%)

, MXIM

Maxim Integrated

$64.10 /

-0.33 (-0.51%)

 
ShowHide Related Items >><<
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
05/21/20 Raymond James
Analog Devices price target raised to $125 from $100 at Raymond James
05/21/20 SunTrust
Analog Devices price target raised to $133 from $124 at SunTrust
05/21/20 RBC Capital
Analog Devices price target raised to $130 from $122 at RBC Capital
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

04/29/20 Credit Suisse
Maxim Integrated price target lowered to $60 from $68 at Credit Suisse
03/30/20 Citi
Maxim Integrated price target lowered to $52 from $65 at Citi
03/20/20
Fly Intel: Top five analyst initiations
03/20/20 Nomura Instinet
Maxim Integrated initiated with a Neutral at Nomura Instinet
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

Periodicals
Wells Fargo bans TikTok from some staff devices due to privacy concerns, FT says » 06:00
07/13/20
07/13
06:00
07/13/20
06:00
WFC

Wells Fargo

$25.47 /

+1.43 (+5.95%)

, AMZN

Amazon.com

$3,204.06 /

+19.57 (+0.61%)

Wells Fargo (WFC) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

07/10/20 Baird
Wells Fargo upgraded to Outperform from Neutral at Baird
07/09/20 Wolfe Research
Wells Fargo upgraded to Peer Perform from Underperform at Wolfe Research
07/08/20 JPMorgan
Wells Fargo price target lowered to $29.50 from $32 at JPMorgan
07/08/20 Seaport Global
Wells Fargo initiated with a Neutral at Seaport Global
AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

07/12/20 Jefferies
Walmart/Target e-comm growth not seen coming at Amazon's expense, says Jefferies
07/10/20 Citi
Amazon.com price target raised to $3,550 from $2,700 at Citi
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/09/20 Credit Suisse
Consumer survey highlights good initial interest in Walmart+, says Credit Suisse
WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

WFC Wells Fargo
$25.47 /

+1.43 (+5.95%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

Upgrade
DCP Midstream upgraded to Neutral from Sell at UBS » 06:00
07/13/20
07/13
06:00
07/13/20
06:00
DCP

DCP Midstream

$10.06 /

+0.285 (+2.92%)

UBS analyst Shneur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

06/23/20 Jefferies
DCP Midstream, Phillips 66 and Holly Energy Partners cut to Hold at Jefferies
06/23/20 Jefferies
DCP Midstream downgraded to Hold from Buy at Jefferies
05/04/20 Mizuho
DCP Midstream price target lowered to $10 from $24 at Mizuho
04/27/20 UBS
DCP Midstream downgraded to Sell from Neutral at UBS
DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

Downgrade
BMO downgrades HCA to Market Perform on 'build-up of risks' » 05:58
07/13/20
07/13
05:58
07/13/20
05:58
HCA

HCA Healthcare

$96.67 /

+2.32 (+2.46%)

BMO Capital analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$96.67 /

+2.32 (+2.46%)

HCA HCA Healthcare
$96.67 /

+2.32 (+2.46%)

05:42 Today BMO Capital
HCA Healthcare downgraded to Market Perform from Outperform at BMO Capital
06/09/20 Barclays
Barclays upgrades Universal Health on higher mental health demand
05/29/20 Mizuho
HCA Healthcare price target lowered to $136 from $150 at Mizuho
04/27/20 UBS
HCA Healthcare price target lowered to $138 from $183 at UBS
HCA HCA Healthcare
$96.67 /

+2.32 (+2.46%)

HCA HCA Healthcare
$96.67 /

+2.32 (+2.46%)

HCA HCA Healthcare
$96.67 /

+2.32 (+2.46%)

Downgrade
HelloFresh downgraded to Neutral from Overweight at JPMorgan » 05:54
07/13/20
07/13
05:54
07/13/20
05:54
HLFFF

HelloFresh

$0.00 /

+ (+0.00%)

JPMorgan analyst Marcus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLFFF HelloFresh
$0.00 /

+ (+0.00%)

07/07/20 Barclays
HelloFresh price target raised to EUR 55 from EUR 40 at Barclays
06/16/20 JPMorgan
HelloFresh price target lowered to EUR 47 from EUR 50 at JPMorgan
06/10/20 Deutsche Bank
HelloFresh price target raised to EUR 47 from EUR 40 at Deutsche Bank
06/05/20 JPMorgan
HelloFresh remains top pick in media space, says JPMorgan
Downgrade
China Mobile downgraded to Reduce from Neutral at New Street » 05:53
07/13/20
07/13
05:53
07/13/20
05:53
CHL

China Mobile

$35.70 /

-0.45 (-1.24%)

New Street Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHL China Mobile
$35.70 /

-0.45 (-1.24%)

CHL China Mobile
$35.70 /

-0.45 (-1.24%)

03/19/20 New Street
China Mobile upgraded to Buy from Reduce at New Street
10/01/19 Daiwa
China Mobile upgraded to Buy from Outperform at Daiwa
09/17/19 Goldman Sachs
China Unicom upgraded to Buy from Neutral at Goldman Sachs
08/15/19 Bernstein
China Mobile upgraded to Outperform from Market Perform at Bernstein
CHL China Mobile
$35.70 /

-0.45 (-1.24%)

Hot Stocks
Ubisoft announces executive departures after misconduct accusations » 05:52
07/13/20
07/13
05:52
07/13/20
05:52
UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

Ubisoft announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

04:40 Today Jefferies
Ubisoft downgraded to Hold from Buy at Jefferies
04:37 Today Societe Generale
Ubisoft downgraded to Hold from Buy at Societe Generale
07/08/20 Morgan Stanley
Ubisoft price target raised to EUR 90 from EUR 80 at Morgan Stanley
07/07/20 Barclays
Ubisoft price target raised to EUR 76 from EUR 66 at Barclays
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.